top of page

Телефон: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Главная >

Mounjaro 2.5mg Injection

Mounjaro 2.5mg Injection

Manufacturer/Marketed By : ELI LILLY AND COMPANY INDIA PVT LTD

$139.76 $30.40

Mounjaro 2.5mg Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, representing a first-in-class dual-incretin therapy. This...

Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.

TIRZEPATIDE

Active Pharmaceutical Ingredient

Mounjaro 2.5mg Injection

Артикул: MOUNJARO-2-5MG-INJECTION
Первоначальная цена

139,76 $

Спеццена

30,40 $

Mounjaro 2.5mg Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, representing a first-in-class dual-incretin therapy. This Mounjaro 2.5mg solution for injection is primarily used to manage blood sugar levels in adults with type 2 diabetes mellitus who are unable to achieve adequate glycemic control through oral antidiabetic medications, diet, and exercise. Mounjaro 2.5mg for type 2 diabetes has become a preferred choice for many patients due to its effectiveness in controlling glucose levels. By mimicking the action of two natural incretin hormones GLP-1 and GIP. Mounjaro 2.5mg injection enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. These mechanisms help lower post-meal blood sugar levels and improve overall metabolic control. Administered once weekly via subcutaneous injection, whether as a Mounjaro 2.5mg pen or Mounjaro 2.5mg vial, it offers convenience and long-term benefits for diabetes management. Guidance on Mounjaro 2.5mg how to inject should always be followed to ensure safe administration. While Mounjaro 2.5mg for weight loss has shown potential in clinical trials, it is not approved for weight loss or the treatment of obesity without a valid prescription and proper medical evaluation. Its off-label use for weight management, including Mounjaro 2.5mg uses for weight loss, should only occur under the supervision of a healthcare professional. Caution is advised in individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disorders. Patients interested in buy Mounjaro 2.5mg online India or checking the Mounjaro 2.5mg price in India should consult a licensed pharmacy or healthcare provider. For guidance on dosing, the Mounjaro 2.5mg dosage schedule should be strictly followed. Many users also refer to Mounjaro 2.5mg review India to understand real-world experiences and outcomes. For those looking to obtain it locally, information on where to buy Mounjaro 2.5mg pen India is available from authorized distributors.

Active Pharmaceutical Ingredient

TIRZEPATIDE

Применение

• Used along with diet and exercise to improve glycemic control in type 2 diabetes.
• Sometimes used off-label for weight management under medical supervision, but not officially approved for this purpose.

Преимущества

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Побочные эффекты

Mounjaro 2.5mg side effects are

Наиболее распространенные побочные эффекты

• Pancreatitis
• Thyroid tumors
• Severe hypoglycemia (especially with insulin use)
• Kidney issues due to dehydration

Распространенные побочные эффекты

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Loss of appetite

Как использовать

Inject subcutaneously once a week into the abdomen, thigh, or upper arm. The initial dose is 2.5 mg weekly, which may be increased to 5 mg after 4 weeks, and then gradually titrated up to 15 mg depending on tolerance and blood sugar response. Always rotate injection sites to avoid skin irritation.

Рекомендации по безопасности

• Breast Feeding: It is unknown whether Mounjaro 2.5mg Injection passes into breast milk. Breastfeeding mothers should seek medical advice.
• Pregnancy: Animal studies indicate potential harm to the fetus. Use during pregnancy only if clearly necessary.
• Lungs: No significant respiratory effects have been reported. Safe for individuals without lung complications.
• Liver: Use with caution in patients with liver impairment. Regular monitoring of liver enzymes is advisable.
• Alcohol: Consuming alcohol may increase the risk of hypoglycemia. Limit alcohol intake while using this medication.
• Driving: Dizziness or hypoglycemia may affect alertness. Exercise caution when operating machinery.

Отказ от ответственности

Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.

Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.

Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.

Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.

bottom of page